The bacterial ribosome, a promising focus for structure-based drug design

Current Opinion in Pharmacology

Volumn 2, Issue 5, 2002, Pages 501-506

  Knowles, David J C ^a   Foloppe, Nicolas ^a   Matassova, Natalia B ^a   Murchie, Alastair I H ^a  

^a RiboTargets Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; EVERNIMICIN; GLYCYLCYCLINE DERIVATIVE; KETOLIDE; LARGE SUBUNIT RIBOSOMAL RNA; LINEZOLID; MACROLIDE; NEAMINE; OXAZOLIDINONE DERIVATIVE; PAROMOMYCIN; PLEUROMUTILIN; POLYPEPTIDE ANTIBIOTIC AGENT; PYRIMIDINE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBONUCLEOPROTEIN; RIBOSOME RNA; ROXITHROMYCIN; SMALL SUBUNIT RIBOSOMAL RNA; STREPTOGRAMIN DERIVATIVE; TAN 1057A; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TIGECYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; CHEMICAL MODIFICATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG BINDING; DRUG BINDING SITE; DRUG CLASSIFICATION; DRUG DESIGN; DRUG STRUCTURE; HUMAN; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; PRIORITY JOURNAL;

EID: 0036791606     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(02)00205-9     Document Type: Review

References (59)

1. Chopra I: New drugs for superbugs. Microbiology Today 2000, 27:4-6.
2. Zurenko GE, Gibson JK, Shinabarger DL, Aristoff PA, Ford CW, Tarpley WG: Oxazolidinones: a new class of antibacterials. Curr Opin Pharmacol 2001, 1:470-476.
3. Ramakrishnan V: Ribosome structure and the mechanism of translation. Cell 2002, 108:557-572.
4. Payne DJ, Holmes DJ, Rosenberg M: Delivering novel targets and antibiotics from genomics. Curr Opin Invest Drugs 2001, 2:1028-1034.
5. Silver LL, Bostian KA: Screening of natural products for antimicrobial agents. Eur J Clin Microbiol Infect Dis 1990, 9:455-461.
6. Brodersen DE, Clemons WM Jr, Carter AP, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V: The structural basis for the action of the antibiotics tertracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell 2000, 103:1143-1154.
7. Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V: Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature 2000, 407:340-348.
8. Nissen P, Hansen J, Ban N, Moore PB, Steitz TA: The structural basis of ribosome activity in peptide bond synthesis. Science 2000, 289:920-930.
9. Schlünzen F, Zarivach R, Harms J, Bashan A, Tocilj A, Albrecht R, Yonath A, Franceschi F: Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 2001, 413:814-821.
10. Adrian PV, Mendrick C, Loebenberg D, McNicholas P, Shaw KJ, Klugman KP, Hare RS, Black TA: Evernimicin (SCH27899) inhibits a novel ribosomal target site: analysis of 23S ribosomal mutants. Antimicrob Agents Chemother 2000, 44:3101-3106.
11. Springer B, Kidan YG, Prammananan T, Ellrott K, Bottger EC, Sander P: Mechanisms of streptomycin resistance: selection of mutations in the 16S rRNA gene conferring resistance. Antimicrob Agents Chemother 2001, 45:2877-2884.
12. Tait-Kamradt A, Davies T, Cronan M, Jacobs MR, Appelbaum PC, Sutcliffe J: Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother 2000, 44:2118-2125.
13. Adrian PV, Zhao W, Black TA, Shaw KJ, Hare RS, Klugman KP: Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action. Antimicrob Agents Chemother 2000, 44:732-738.
14. Sucheck SJ, Wong CH: RNA as a target for small molecules. Curr Opin Chem Biol 2000, 4:678-686.
15. Haddad J, Kotra LP, Llano-Sotelo B, Kim C, Azucena EF Jr, Liu M, Vakulenko SB, Chow CS, Mobashery S: Design of novel antibiotics that bind to the ribosomal acyltransfer site. J Am Chem Soc 2002, 124:3229-3237.
16. Chopra I: Glycylcyclines: third-generation tetracycline antibiotics. Curr Opin Pharmacol 2001, 1:464-469.
17. Johnson AP: GAR-936. Curr Opin Anti-Infect Invest Drugs 2000, 2:164-170.
18. Gordeev MF: Combinatorial lead discovery and optimization of antimicrobial oxazolidinones. Curr Opin Drug Discov Dev 2001, 4:450-461.
19. Cocito C, Di Giambattista M, Nyssen E, Vannuffel P: Inhibition of protein synthesis by streptogramins and related antibiotics. J Antimicrob Chemother 1997, 39:7-13.
20. Pfeil E, Wiedemann B: Pronounced postantibiotic effect of quinupristin-dalfopristin in static cultures of Staphylococcus aureus: an effect not seen with other antibiotics. Antimicrob Agents Chemother 2000, 44:1059-1061.
21. Lamb HM, Figgitt DP, Faulds D: Quinupristin/dalfopristin: a review of its use in the management of serious Gram-positive infections. Drugs 1999, 58:1061-1097.
22. Poulsen SM, Karlsson M, Johansson LB, Vester B: The pleuromutilin drugs tiamulin and valnemulin bind to the RNA at the peptidyl transferase centre on the ribosome. Mol Microbiol 2001, 41:1091-1099.
23. Belova L, Tenson T, Xiong L, McNicholas PM, Mankin AS: A novel site of antibiotic action in the ribosome: interaction of evernimicin with the large ribosomal subunit. Proc Natl Acad Sci USA 2001, 98:3726-3731.
24. Williams RM, Yuan C, Lee VJ, Chamberland S: Synthesis and antimicrobial evaluation of TAN-1057A/B analogs. J Antibiot (Tokyo) 1998, 51:189-201.
25. Bernstein FC, Koetzle TF, Williams GJ, Meyer EF Jr, Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasumi M: The protein data bank: a computer-based archival file from macromolecular structures. J Mol Biol 1977, 122:535-542.
26. Fourmy D, Recht MI, Blanchard SC, Puglisi JD: Structure of the A-site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science 1996, 274:1367-1371.
27. Fourmy D, Yoshizawa S, Puglisi JD: Paromomycin binding induces a local conformational change in the A-site of 16S rRNA. J Mol Biol 1998, 277:333-345.
28. Fourmy D, Recht MI, Puglisi JD: Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16S rRNA. J Mol Biol 1998, 277:347-362.
29. Moore PB: The ribosome at atomic resolution. Biochemistry 2001, 40:3243-3250.
30. Ogle JM, Brodersen DE, Clemons WM Jr, Tarry MJ, Carter AP, Ramakrishnan V: Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science 2001, 292:897-902.
31. Vincens Q, Westhof E: Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site. Structure 2001, 9:647-658.
32. Abagayan R, Totrov M: High-throughput docking for lead generation. Curr Opin Chem Biol 2001, 5:375-382.
33. Schneider G, Böhm HJ: Virtual screening and fast automated docking methods. Drug Discov Today 2002, 7:64-70.
34. Leclerc F, Karplus M: MCSS-based predictions of RNA binding sites. Theor Chem Acc 1999, 101:131-137.
35. Chen Q, Shafer RH, Kuntz ID: Structure-based discovery of ligands targeted to the RNA double helix. Biochemistry 1997, 36:11402-11407.
36. Filikov AV, Mohan V, Vickers TA, Griffey RH, Cook PD, Abagyan RA, James TL: Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR. J Comput Aided Mol Design 2000, 14:593-610.
37. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA: Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA 2001, 98:10037-10041.
38. Ma C, Baker NA, Joseph S, McCammon JA: Binding of the aminoglycoside antibiotics to the small ribosomal subunit: a continuum electrostatics investigation. J Am Chem Soc 2002, 124:1438-1442.
39. Pearlman DA, Charifson PS: Are free energy calculations useful in practice? A comparison with rapid scoring functions for the p38 MAP kinase protein system. J Med Chem 2001, 44:3417-3423.
40. Norberg J, Nilsson L: Molecular dynamics applied to nucleic acids. Acc Chem Res 2002, 35:465-472.
41. Auffinger P, Westhof E: Simulations of the molecular dynamics of nucleic acids. Curr Opin Struct Biol 1998, 8:227-236.
42. Douthwaite S, Champney WS: Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site. Antimicrob Agents Chemother 2001, 48:1-8.
43. Xiong L, Kloss P, Douthwaite S, Andersen NM, Swaney S, Shinabarger DL, Mankin AS: Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action. J Bacteriol 2000, 182:5325-5331.
44. Sander P, Prammananan T, Boettger E: Introducing mutations into a chromosomal rRNA gene using a genetically modified eubacterial host with a single rRNA operon. Mol Microbiol 1996, 22:841-848.
45. Asai T, Zaporojets D, Squires C, Squires CL: An Escherichia coli strain with all chromosomal rRNA operons inactivated: complete exchange of rRNA genes between bacteria. Proc Natl Acad Sci USA 1999, 96:1971-1976.
46. Rodnina MV, Wintermeyer W: Fidelity of aminoacyl-tRNA selection on the ribosome: kinetic and structural mechanisms. Annu Rev Biochem 2001, 70:415-435.
47. Spahn CM, Beckmann R, Eswar N, Penczek PA, Sali A, Blobel G, Frank J: Structure of the 80S ribosome from Saccharomyces cerevisiae - tRNA-ribosome and subunit-subunit interactions. Cell 2001, 107:373-386.
48. Stark H, Rodnina MV, Wieden HJ, van Heel M, Wintermeyer W: Large-scale movement of elongation factor G and extensive conformational change of the ribosome during translocation. Cell 2000, 100:301-309.
49. Zhou CC, Swaney SM, Shinabarger DL, Stockman BJ: 1H nuclear magnetic resonance study of oxazolidinone binding to bacterial ribosomes. Antimicrob Agents Chemother 2002, 46:625-629.
50. Sannes-Lowery KA, Griffey RH, Hofstadler SA: Measuring dissociation constants of the aminoglycoside antibiotics by electrospray ionisation mass spectrometry. Anal Biochem 2000, 280:264-271.
51. Wimberly BT, Brodersen DE, Clemons WM Jr, Morgan-Warren RJ, Carter AP, Vonrhein C, Hartsch T, Ramakrishnan V: Structure of the 30S ribosomal subunit. Nature 2000, 407:327-339.
52. Pioletti M, Schlunzen F, Harms J, Zarivach R, Gluhmann M, Avila H, Bashan A, Bartels H, Auerbach T, Jacobi C et al.: Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3. EMBO J 2001, 20:1829-1839.
53. Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Hartsch T, Wimberly BT, Ramakrishnan V: Crystal structures of an initiation factor bound to the 30S ribosomal subunit. Science 2001, 291:498-501.
54. Ban N, Nissen P, Hansen J, Moore PB, Steitz TA: The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Science 2000, 289:905-920.
55. Yusupov MM, Yusopova GZH, Baucom A, Lieberman K, Earnest TN, Cate J, Noller HF: Crystal Structure of the Ribosome at 5.5A Resolution. Science 2001, 292:883-889.
56. Agalarov SC, Sridhar Prasad G, Funke PM, Stout CD, Williamson JR: Structure of the S15,S6,S18-rRNA complex: assembly of the 30S ribosome central domain. Science 2000, 288:107-113.
57. Wimberley BT, Guymon R, McCutcheon JP, White SW, Ramakrishnan V: A detailed view of a ribosomal active site: the structure of the L11-RNA complex. Cell 1999, 97:491-502.
58. Conn GL, Draper DE, Lattman EE, Gittis AG: Crystal structure of a conserved ribosomal protein-RNA complex. Science 1999, 284:1171-1174.
59. Humphrey W, Dalke A, Schulten K: VMD - visual molecular dynamics. J Mol Graph 1996, 14:33-38.